“DELIVERING PATIENT-ORIENTED PRODUCTS OF HIGHEST QUALITIES; ESTABLISHING MARKET TRENDS”
Over the past 18 years, Jeilmedix Pharmaceutical Company (hereby JMP), has consistently been at the forefront of Korean pharmaceutical and healthcare industries, putting into practice our shared ideals of bringing patients and clients’ needs first. By delivering products of highest qualities that are responsive to patients’ specific requirements, we have been establishing our own niche markets and trends in Korea and around the world. Furthermore, we are actively involved in partnering, licensing, developing and commercializing specialty prescription medicine, OTC, medical-aesthetic and consumer healthcare fields. Today, by continuously exploring new opportunities via embracing innovation and global partnerships while putting the needs of patients and clients first, JMP strives to advance the healthcare market, helping people around the world live healthier, happier lives.
We regard integrity as our core value, as we understand the
significance and the responsibility of our role as a contributor to the
well-being of people and society at large.
Therefore, we always ensure to maintain a strict production process
using only safe and trusted ingredients of high qualities, work with
the right people who share same values as us, and offer fair and
competitive pricing for our partners and consumers.
We firmly believe in the notion of collective success, therefore our
stakeholders success is our success. We believe that success is
defined by everyone working together in harmony.
We strive for longevity in everything we do - longevity for our
consumers and employees, management team, partners and the
environment. To achieve this, we believe sustainable values must
be created and shared amongst all of our stakeholders. Instead of
chasing after fleeting trends and short-term goals, we strive for a
steady long-term growth ensuring a sustainable vision for all.
Commercialization, direct sales & marketing of:
prescription, specialty medicine (inc. both reimbursement, and non-reimbursement)
OTC/BTC healthcare & medical aesthetic products
consumer healthcare products for mass market
Quality assurance management and distribution based on:
KGSP (for medicine)
KGIP (imported medical device)
others (approved quality system for imported supplements, cosmetics and food)
response to authorities
consistent regulatory filing
JMBIOTECH Corporation Limited (hereby JMB) became an independent subsidiary from JMP in 2012. JMB specializes in R&D, manufacturing, and international business in medical aesthetic and drug delivery system (DDS) fields, whilst ensuring JMP maintains cutting edge of distribution in Korean healthcare market and consistent investments to JMB as a mother company.